(19)
(11) EP 2 114 438 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
03.10.2012 Bulletin 2012/40

(45) Mention of the grant of the patent:
29.08.2012 Bulletin 2012/35

(21) Application number: 08704601.7

(22) Date of filing: 04.01.2008
(51) International Patent Classification (IPC): 
A61K 38/28(2006.01)
(86) International application number:
PCT/KR2008/000061
(87) International publication number:
WO 2008/082274 (10.07.2008 Gazette 2008/28)

(54)

AN INSULINOTROPIC COMPLEX USING AN IMMUNOGLOBULIN FRAGMENT

INSULINOTROPER KOMPLEX MIT EINEM IMMUNGLOBULIN-FRAGMENT

COMPLEXE INSULINOTROPIQUE CONTENANT UN FRAGMENT D'IMMUNOGLOBULINE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

(30) Priority: 05.01.2007 KR 20070001662

(43) Date of publication of application:
11.11.2009 Bulletin 2009/46

(73) Proprietor: Hanmi Science Co., Ltd.
Gyeonggi-do 445-813 (KR)

(72) Inventors:
  • SONG, Dae Hae
    Seoul 151-704 (KR)
  • LIM, Chang Ki
    Suwon-si Gyeonggi-do 443-470 (KR)
  • SONG, Tae Hun
    Yongin-si Gyeonggi-do 446-731 (KR)
  • KIM, Young Hoon
    Seoul 150-797 (KR)
  • KWON, Se Chang
    Seoul 143-751 (KR)
  • LEE, Gwan Sun
    Seoul 138-739 (KR)
  • JUNG, Sung Youb
    Suwon-si Gyeonggi-do 443-470 (KR)
  • CHOI, In Young
    Yongin-si Gyeonggi-do 448-755 (KR)

(74) Representative: Goodall, Scott et al
Sagittarius IP Taylor House 39 High Street
Marlow Buckinghamshire SL7 1AF
Marlow Buckinghamshire SL7 1AF (GB)


(56) References cited: : 
WO-A1-2005/047334
WO-A1-2006/107124
WO-A2-2004/093823
 WO-A1-2006/068910
WO-A1-2006/124529
WO-A2-2005/000892
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).